Biofrontera's US-listed shares fall as Q3 revenue misses estimates

Biofrontera

14/11/2024 18:38

** U.S.-listed shares of Biofrontera Inc  BFRI.O  fall 11%
to 74 cents
    ** On Wednesday, company reported Q3 rev. of $9 mln, missing
two analysts' average est. of $10 mln, due to disruption from
hurricanes
        ** Q3 loss of 98 cents/shr wider than est. loss of 84
cents/shr, according to data compiled by LSEG
  
    ** BFRI likely to report strong Q4 revenue, as demand for
Ameluz, company's treatment for a type of skin condition,
increases in less-sunny weather - Brokerage Roth MKM 
        ** Company to also benefit from Ameluz price hike of
October and hurricane-interrupted sales moving into the quarter
- Roth MKM
  
    ** Including session gains, BFRI down 73.5% YTD

 (Reporting by Kamal Choudhury in Bengaluru)
 ((Kamal.Choudhury@thomsonreuters.com;))